Brind.

Xu Wang was appointed Director and CEO of LakeShore Biopharma Co., Ltd. on August 1, 2025, amidst ongoing litigation with former Chairman Yi Zhang.

1 report, 1 independent Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Xu Wang was appointed Director and CEO of LakeShore Biopharma Co., Ltd. on August 1, 2025, amidst ongoing litigation with former Chairman Yi Zhang.

Who's involved

What this event is mainly about
Xu WangYi Zhang

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireLakeShore Biopharma Announces Fiscal Year 2025 Financial Results Total revenue reached RMB615.0 million, representing 7.2% year-over-year growth Gross profit rose to RMB507.2 million, up 11.3% year-o